...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Biotech Showcase
2
Dec 17, 2018 12:24PM

Also, both Resverlogix and Zenith are listed as presenting companies at BIO CEO Investor Conference in New York February 11-12, 2019

5
Dec 26, 2018 04:40PM
3
Jan 08, 2019 11:15AM
Share
New Message
Please login to post a reply